Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer

PeerJ

article

Qiongyun Chen¹  Xiaoqing Huang²  Xuan Dong¹  Jingtong Wu¹  Fei Teng³  Hongzhi Xu¹ 

[1] Department of Gastroenterology, Zhongshan Hospital, Xiamen University;Department of Chinese Tranditional Medicine, Zhongshan Hospital, Xiamen University;Department of Endocrinology, the First Affiliated Hospital of Xiamen University

关键词: ERICH3-AS1;    Gastric cancer;    Prognosis;    Tumorigenesis;   

DOI  :  10.7717/peerj.8050

学科分类：社会科学、人文和艺术（综合）

来源: Inra

【 摘 要 】

Long non-coding RNAs (lncRNAs) play important roles in gastric cancer (GC), but the mechanism is not fully clear. ERICH3-AS1 (ERICH3 antisense RNA1) is affiliated with the non-coding RNA class which has proven to be involved in the prognostic of GC, but the function of ERICH3-AS1 is still unclear. In this study, we aim to explore the potential function of ERICH3-AS1 in the development of GC and analyze the prognostic role of ERICH3-AS1 in GC. We found that the lncRNA ERICH3-AS1 was significantly up-regulated in GC tissues in the analysis of The Cancer Genome Atlas (TCGA) data; the Kaplan-Meier analysis showed that the higher the expression of ERICH3-AS1 was, the earlier the recurrence and the poorer the prognosis would be in patients. Cox univariate and multivariate analyses revealed that ERICH3-AS1 was a risk factor of disease-free survival (DFS) (p < 0.05) and overall survival (OS) (p < 0.05) of patients. Through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, it demonstrated that the ERBB pathways, the mitogen-activated protein kinase (MAPK) pathways, the MTOR pathways, p53 pathways and Wnt pathways were differentially enriched in ERICH3-AS1 high expression phenotype. Furthermore, the correlation analysis showed that ERICH3-AS1 had significant correlations with apoptosis-related proteins such as BCL2L10 and CASP14; cell cycle-associated proteins CDK14 and invasion and migration-associated proteins such as MMP20, MMP26 and MMP27. In summary, we identified that increased ERICH3-AS1 might be a potential biomarker for diagnosis and independent prognostic factor of GC. Moreover, ERICH3-AS1 might participate in the oncogenesis and development of tumors via cell cycle and apoptosis pathway mediated by ERBB, MAPK, MTOR, p53 and Wnt pathways.

【 授权许可】

CC BY